AirSculpt has entered a national partnership with Tiger Aesthetics to introduce alloClae, a structural adipose tissue allograft for body contouring, at select locations beginning in August.
AirSculpt has announced a national partnership with Tiger Aesthetics to offer alloClae, an off-the-shelf structural adipose tissue designed for aesthetic body procedures. The product will launch at select AirSculpt locations in August, with the company planning to expand availability nationwide by the end of 2026.
New Option for Volume Restoration and Contour Refinement
The partnership adds alloClae to AirSculpt’s body enhancement offerings for patients seeking volume restoration and contour refinement, including patients who may not have sufficient fat for a traditional fat transfer procedure.
According to the announcement, alloClae may be incorporated into treatment plans involving the hips, buttocks, and breasts, as well as contour irregularities following liposuction.
“At AirSculpt, we’re continually evaluating new technologies that complement our expertise and meaningfully expand what’s possible for our patients,” said Yogi Jashnani, chief executive officer of AirSculpt. “Our partnership with Tiger Aesthetics reflects our commitment to remaining at the forefront of body contouring innovation while giving more patients access to personalized solutions through our national network. We’re excited to introduce alloClae as another way to help patients achieve natural-looking results tailored to their individual goals.”
Companies Cite Changing Body Contouring Demand
AirSculpt said it is expanding its treatment portfolio as demand for minimally invasive body contouring and body enhancement grows, driven in part by the use of GLP-1 medications and changing aesthetic goals.
“With the growing use of weight loss medications and increasing consumer demand for regenerative treatments, alloClae provides a unique, non-surgical option for patients to restore targeted volume in a fully natural way,” said Caro Van Hove, president of Tiger Aesthetics. “This partnership is a natural fit that expands access for patients nationwide and enables AirSculpt to help patients who otherwise have very limited options.”
About alloClae
alloClae is a structural adipose tissue allograft used for nonsurgical body contouring. It is designed to add targeted volume, restore balance, smooth contours, and enhance a patient’s natural shape.
According to the announcement, the procedure is typically performed in an office in under an hour, with immediate results and minimal downtime.
AirSculpt said additional treatment options, treatment areas, and clinic availability will be announced nationwide throughout 2026.
Photo: AirSculpt
